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Abstract
Background: The corpus callosum is the largest white matter structure in the brain, and it is the most consistently
reported to be atypical in diffusion tensor imaging studies of autism spectrum disorder. In individuals with typical
development, the corpus callosum is known to undergo a protracted development from childhood through young
adulthood. However, no study has longitudinally examined the developmental trajectory of corpus callosum in
autism past early childhood.
Methods: The present study used a cohort sequential design over 9 years to examine age-related changes of the corpus
callosum in 100 males with autism and 56 age-matched males with typical development from early childhood
(when autism can first be reliably diagnosed) to mid-adulthood (after development of the corpus callosum has
been completed) (3 to 41 years of age).
Results: The group with autism demonstrated a different developmental trajectory of white matter
microstructure in the anterior corpus callosum’s (genu and body) fractional anisotropy, which suggests
atypical brain maturation in these regions in autism. When analyses were broken down by age group, atypical
developmental trajectories were present only in the youngest participants (10 years of age and younger).
Significant main effects for group were found in terms of decreased fractional anisotropy across all three
subregions of the corpus callosum (genu, body, and splenium) and increased mean diffusivity, radial diffusivity,
and axial diffusivity in the posterior corpus callosum.
Conclusions: These longitudinal results suggest atypical early childhood development of the corpus callosum
microstructure in autism that transitions into sustained group differences in adolescence and adulthood. This
pattern of results provides longitudinal evidence consistent with a growing number of published studies and
hypotheses regarding abnormal brain connectivity across the life span in autism.
Keywords: Diffusion tensor imaging, Brain development, Developmental disorders, Childhood, Adolescence,
Adulthood
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Background
Autism spectrum disorder (ASD) is a genetically com-
plex neurodevelopmental disorder that may be marked
by atypical functional connectivity within and between
particular neural networks and regions in the brain
[1-4]. Atypical functional connectivity may implicate
white matter, which contains bundles of axons that allow
for fast and efficient neuronal communication [5]. The
largest white matter tract is the corpus callosum, which
facilitates interaction between the left and right hemi-
spheres across multiple lobes. Studies in individuals with
callosal agenesis or with a surgically severed corpus cal-
losum suggest that the corpus callosum is involved in a
diversity of functions but may be particularly involved in
cognitive processes that require the integration of com-
plex information (for a review, see [6]). Because persons
with ASD have been shown to demonstrate difficulty
with higher order or complex information processing
tasks [7-9], the corpus callosum may be a key area of
study in this disorder, and within-group corpus callosum
differences may be able to help disentangle aspects of
the clinical heterogeneity commonly observed in ASD.
Multiple sources of evidence suggest corpus callosum
atypicalities in persons with ASD. The corpus callosum
was one of the first brain structures observed to be ab-
normal in in vivo neuroimaging studies of autism
[10-14]. Decreased mean size of the corpus callosum, es-
pecially the anterior aspects [15], is one of the most rep-
licated structural imaging results of case-control studies
of ASD (for a meta-analysis, see [16]). Functional con-
nectivity measures have suggested decreased interhemi-
spheric connectivity in young children, adolescents, and
adults with ASD [2,17-19]. Because the corpus callosum
is composed predominately of parallel myelinated axon
bundles in primates [20], it is well suited for investiga-
tion using diffusion tensor imaging (DTI) [21] to exam-
ine the microstructural integrity of the corpus callosum
in persons with ASD. DTI is based upon a Gaussian
model of water diffusion in tissue and provides a descrip-
tion of white matter microstructure through the tensor
measures, including the fractional anisotropy (FA), mean
diffusivity (MD), radial diffusivity (RD), and axial diffu-
sivity (AD). These DTI measures provide complimentary
information about the microstructure of the corpus
callosum. For example, MD is the average diffusivity
over all directions and is inversely related to the dens-
ity of cellular membranes. RD is defined as the short-
est eigenvector of the diffusion tensor (perpendicular
to the corpus callosum white matter fibers) and has
been associated with myelin abnormalities [22,23].
AD is defined as the longest eigenvector of the diffu-
sion tensor (parallel to the corpus callosum fibers)
and is affected in axonal injury and sensitive to cyto-
skeletal features [24]. FA is a normalized measure of
variance among the lengths of all three eigenvectors
of the diffusion tensor. An FA close to zero represents
isotropic diffusion with equally long eigenvectors, and
an FA of one represents highly directional diffusion
with maximal elongation of one eigenvector compared to
the others.
FA has been the most common measure of white mat-
ter microstructure used in DTI studies of autism [25],
but it is encouraged to supplement measures of FA with
measures of MD, RD, and AD in order to more accurately
characterize white matter microstructure [26]. White mat-
ter microstructure and corresponding DTI values can be
affected by changes in myelination, axonal density, axonal
degeneration, axonal packing, neuroinflammation, fiber
crossing, fiber curving, or fiber branching. The specific
pattern of group differences across FA, MD, RD, and AD
may be more indicative of one type of white matter atypi-
cality than another [24], suggesting the need to examine
the pattern of results across all of the available metrics.
A number of recent studies have used DTI methods in
cross-sectional examinations of white matter in ASD,
and one of the most consistent findings is decreased FA
and increased MD of the corpus callosum in ASD (for a
review, see [25]). In addition, a subset of these studies
has shown significantly increased RD but not AD in
ASD [27-32]. Increased RD may reflect a thinner myelin
sheath of the axons [33,22,23,34], which suggests that
the axons in the white matter tracts of the corpus callo-
sum are less myelinated in persons with ASD.
Despite the consistency of these results, there are a
handful of studies that have found either increased FA
or no group differences in corpus callosum microstruc-
ture [32,35-37]. Two of these studies investigated very
young subjects (that is, 1.8-to-3.3-year-old children in
[35] and 1.5-to-5.8-year-old children in [32]), and it is
possible that this discrepancy in findings may be due to
developmental effects very early in life. Indeed, in indi-
viduals with typical development, cross-sectional and
longitudinal studies suggest that white matter tracts, in-
cluding the corpus callosum, tend to increase in FA and
decrease in MD from childhood into adulthood [38-43],
and if there is a differing developmental trajectory of the
white matter integrity in ASD, the detection of group
differences may be more or less likely at particular ages.
Only longitudinal studies can satisfactorily examine
developmental trajectories, and to date, only one longi-
tudinal DTI study in ASD has been conducted in very
young children. Wolff and colleagues [44] found that the
high-risk infants who went on to develop ASD demon-
strated significantly greater FA of the corpus callosum at
6 months of age, no difference in FA at 12 months of
age, and significantly decreased FA at 24 months of age
compared to high-risk infants who did not go on to de-
velop ASD. These results suggest that young children
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who develop ASD may undergo distinct development of
the corpus callosum microstructure during infancy.
However, studies of older children and adults with ASD
are needed. In typically developing individuals, the corpus
callosum undergoes an uneven and prolonged develop-
mental trajectory that likely continues through adoles-
cence [39-43]. This protracted development of the corpus
callosum through childhood and adolescence and indica-
tions of atypical corpus callosum structure in ASD dem-
onstrate the need for a longitudinal examination of the
corpus callosum in children, adolescents, and adults.
Understanding the development of the corpus callosum
in ASD may be critical, given that atypical development of
this structure could have cascading effects on other as-
pects of brain development, including early cortical devel-
opment and the formation of synchronous neuronal
assemblies [45,46].
The present study extends the cross-sectional study of
Alexander and colleagues [27] to longitudinally examine
DTI age-related changes of the corpus callosum of 100
individuals with ASD and 56 age-matched individuals
with typical development from early childhood (when
ASDs can first be reliably diagnosed) to mid-adulthood
(after development of the corpus callosum has been
completed) (3.0 to 41.8 years old).
Methods
Design
The study employed a cohort sequential design (that is,
an accelerated longitudinal design) [47], which simultan-
eously measured individual longitudinal changes in DTI
measurements across multiple age cohorts. Each partici-
pant was imaged and clinical measures were collected
one to four times over a 9-year period (see Figure 1).
Fifty-six participants had four scans (41 ASD and 15 typ-
ically developing), 36 participants had three scans (22
ASD and 14 typically developing, 38 participants had
two scans (20 ASD and 18 typically developing), and
26 participants had one scan (17 ASD and 9 typically
developing). The average interscan interval was 2.6 years.
Participants
The study protocol was approved by both the University of
Utah and University of Wisconsin-Madison Institutional
Review Boards. Consent was obtained for all participants,
and for participants under the age of 18 years, both paren-
tal consent and participant assent were obtained. All TDC
and the majority of the ASD participants were community
ascertained. Participants for this study included 100 males
with ASD and 56 males with typical development between
the ages of 3 and 41. These participants were selected from
participants in the broader longitudinal neuroimaging
study (110 ASD and 78 TDC). Participants who met cri-
teria for ASD or TDC at enrollment but who were found
to be atypical at future time points (for example, one ASD
participant developed a significant medical disorder affect-
ing the brain; several TDC participants developed depres-
sion), participants who did not have an age match in the
other group, or participants whose scans did not meet
quality control checks (see ‘Imaging protocol’ below) were
excluded. Time 1 data from a subset of these participants
were reported in the study by Alexander and colleagues
[27]. The participants with ASD were diagnosed based on
Autism Diagnostic Interview-Revised [48], Autism Diag-
nostic Observation Scale (ADOS) [49], Diagnostic Statis-
tical Manual-IV-TR [50], and ICD-10 criteria. Participants
with ASD were included in the present study if they met
criteria for a lifetime diagnosis of autistic disorder, Asper-
ger’s syndrome, or pervasive developmental disorder not
otherwise specified (89% met full criteria for autistic dis-
order). Exclusion criteria included medical causes of ASD
(determined by patient history, physical exam, fragile-X
testing, and karyotype), history of severe head injury,
hypoxia-ischemia, seizure disorder, and other neurological
disorders. ASD is thought to be a highly heterogeneous
disorder [51], and the heterogeneity in the IQ domain of
our ASD sample can be seen in the ranges of scores in
Table 1. Typically developing control participants were
confirmed as having typical development through history,
the ADOS, IQ testing, and neuropsychological and stan-
dardized psychiatric assessment. All participants had
English as their first language and were verbal at the
time of testing. Forty-nine participants with ASD reported
being on a centrally active medication (that is, stimulant,
antidepressant, neuroleptic, atypical neuroleptic, or anti-
anxiety medication) during at least one of the scans (38 at
time 1, 31 at time 2, 19 at time 3, and 10 at time 4).
See Table 1 for more detailed participant information.
Figure 1 Age at scan and number of scans for each participant
in the longitudinal corpus callosum analyses. ASD, autism
spectrum disorder; TDC, typically developing controls.
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Assessments
IQ
Standard scores in verbal, nonverbal, and overall ability
(referred to as verbal IQ [VIQ], performance IQ [PIQ],
and full-scale IQ [FSIQ], respectively, despite differences
in terminology across the tests) were assessed in the
participants with ASD and the participants with typical
development at each of the four time points. At time 1,
participants completed the Differential Abilities Scales
[52], Wechsler Intelligence Scale for Children (third
edition) [53], or Wechsler Adult Intelligence Scale
(third edition) [54] (depending on age and verbal ability).
At time 2, participants completed the four subtests of the
Wechsler Abbreviated Scale of Intelligence (WASI) [55];
at time 3, participants completed the two-subtest version
of the WASI; and at time 4, participants completed the
WASI if they had a previous IQ test, or participants com-
pleted the Differential Abilities Scales [52], Wechsler
Intelligence Scale for Children (third edition) [53], or
Wechsler Adult Intelligence Scale (third edition) [54] if
they had not had a previous IQ test.
Imaging protocol
Participants were recruited and scanned at the University
of Utah. Image processing and analyses were conducted at
the University of Wisconsin-Madison. A total of 346 scans
were obtained from the participants (221 ASD scans and
125 TDC scans). Magnetic resonance images were acquired
on a Siemens Trio 3.0 Tesla Scanner (Siemens, Munich,
Germany) at the University of Utah. At all four time points,
the DTI acquisition used a product single-shot, spin-echo,
echo planar imaging (EPI) pulse sequence with diffusion
weighting, performed with bipolar gradients with dual-echo
refocusing to reduce eddy currents [56]. Parallel imaging
with a geometric reduction factor of two was used to re-
duce image distortions from magnetic field inhomogenei-
ties. For each slice, we obtained diffusion-weighted images
in 12 non-collinear diffusion encoding directions with
a b = 1,000 s/mm2 and a single b = 0 image. Sixty contigu-
ous axial slices 2.5 mm thick were acquired over the cere-
brum and cerebellum (matrix = 128 × 128; field of view
[FOV] = 256 mm; resolution = 2 × 2 × 2.5 mm; repetition
time [TR] = 7,000 ms; echo time [TE] = 84 ms at time 1
and 91 ms at times 2, 3, and 4; and pixel bandwidth =
1,346 Hz). The acquisition was repeated four times
(52 volumes total) in 6.5 min. Thirty-two young partici-
pants with ASD received sedation for scanning at time 1,
and fifteen of these same participants received sedation
again at time 2. No sedation was used at times 3 or 4.
Sedation, using a combination of remifentanil and
propofol, followed a strict clinical protocol approved by
the institutional review board by the University of Utah
and performed by an onsite faculty anesthesiologist. No
complications occurred. In several cases, rehearsal was
used to practice lying in the scanner.
Between times 1 and 2, the scanner hardware (primarily
the head coil: an 8-channel receive-only array coil at time 1
and a 12-channel receive-only array coil at times 2, 3,
and 4) and software were upgraded (which accounted
for the TE change described above). To account for
systematic differences in the imaging measurements at
time 1 versus times 2, 3, and 4 due to this upgrade, a
linear regression ‘head coil’ variable (which also accom-
modated for pulse sequence differences) was created and
included in all statistical models. To further ascertain
that the present longitudinal results were not solely
due to noise from this upgrade, all patterns of results
were tested by running time 1 analyses only and then
by dropping time 1 and using only times 2, 3, and 4
data (see Additional file 1, Tables S1 and S2).
DTI image analysis
Diffusion-weighted images (DWI) were corrected for
distortion, translation, and rotation from eddy currents
and bulk head motion using an affine registration tools
implemented in the fMRIB FSL software library [57]. To
exclude regions of extreme intensities prior to process-
ing, a mask was applied that excluded the upper 1% of
the apparent diffusion coefficient, lower 1% of the aver-
age diffusion-weighted map, and lower 1% of the average
b0 maps. The gradient orientation was corrected for ro-
tation [58]. The DWI were smoothed in the axial plane
Table 1 Demographic characteristics of the longitudinal
study sample and P-values for group comparisons
ASD TDC P-value
Number of subjects 100 56 -
Scans per subject, mean (SD) 2.9 (1.1) 2.6 (1.1) 0.18
Scans at time 1 92 43 -
Scans at time 2 75 35 -
Scans at time 3 66 41 -
Scans at time 4 54 28
Total number of scans 287 147 -
Age (years), mean (SD) 18.3 (8.5) 18.9 (7.8) 0.46
Age range 3.3 to 40.6 3.4 to 41.8 -
Interscan interval, mean (SD) 2.7 (0.4) 2.6 (0.5) 0.20
Interscan interval range 1.7 to 3.9 1.6 to 4.4 -
FSIQa mean (SD) 100.1 (17.6) 118.2 (13.2) <0.001
FSIQ range 53 to 138 89 to 153 -
VIQa mean (SD) 96.3 (21.1) 114.7 (13.2) <0.001
VIQ range 51 to 145 87 to 151 -
PIQa mean (SD) 102.6 (17.9) 116.3 (14.8) <0.001
PIQ range 62 to 140 87 to 155 -
ASD, autism spectrum disorder; FSIQ, full-scale IQ; PIQ, performance IQ; TDC,
typically developing controls; VIQ, verbal IQ. a Calculated as mean for each
individual then averaged across each group.
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using a 2D Gaussian kernel with 1.88-mm full width at
half maximum (FWHM). Brain images were then skull-
stripped. Next, the tensors were fit using a robust
estimation algorithm (RESTORE) [59], implemented in
Camino [60]. RESTORE has been shown to substantially
reduce the effects of noise and physiologic artifacts from
DTI maps by removing outliers in DWI measurements
[61].
The eigenvalue maps (λ1, λ2, λ3) were computed from
the estimated diffusion tensors. Maps of the MD (aver-
age of the eigenvalues), FA (the normalized standard
deviation of the eigenvalues reflecting the relative degree
of diffusion anisotropy), AD (λ1 the largest eigenvalue),
and RD (λ3 diffusion perpendicular to the major eigen-
vector) were calculated. The units for MD, RD, and AD
were square millimeter per second, scaled 10−3. Quality
control checks were manually performed on the DTI
images, looking for instances of slice intensity banding,
FA hyperintensities, frontal lobe distortions, or blurring
that could affect the analyses. Additionally, the white
matter masks were checked to make sure that they were
adequately covering the white matter in each brain scan.
After quality control checks on the data, all but six ASD
scans (98.6%) met the quality control standards.
To account for the effects of potential group differ-
ences in head motion during scanning, we computed the
total motion index (TMI) for each participant as de-
scribed in [62,63]. The TMI suggested that head motion
did not differ between groups (P = 0.84) nor across ages
(P = 0.48), but TMI was used as a covariate in all
analyses to ascertain that group differences were not
due to head motion. Additionally, to account for
possible physiological noise, we computed the signal-
to-noise ratio (SNR) for each region of the corpus
callosum in each scan by taking the mean signal from all
the volumes of the scan (b0 and the diffusion weighted
volumes), dividing the signal by the noise in a voxel (noise
estimated using the residual method described in the ap-
pendix of [61]), and then calculating the average SNR
within each corpus callosum region of each scan. SNR of
each region was used as a covariate in all analyses of that
particular region.
A population-specific template was estimated itera-
tively, aligning all the subjects using affine and diffeo-
morphic diffusion tensor registration implemented in
DTI-TK [64]. To segment the corpus callosum and its
subregions (that is, genu, body, and splenium), the JHU
ICBM-DTI-81 template FA [65] was registered to our
population FA template using a diffeomorphic spatial
normalization tool, ANTS [66], and the subregion labels
were transferred to our template using nearest neighbor
interpolation. Using a method similar to that described
by Faria and colleagues [67], these regions of interest
(ROIs) were then transferred to the native space of
each participant using the inverse of the corresponding
spatial transformations estimated during the popula-
tion normalization. Median FA, MD, RD, and AD were
calculated for each ROI. The median was selected as
our measure of central tendency rather than the mean
to protect against sensitivity to voxels with extreme
values. To prevent partial volume effects, we generated
histograms of the MD values for each scan and masked
out any voxels that had MD two standard deviations
above the mean for each scan. Then, corpus callosum
white matter was further refined by masking out voxels
with FA less than two standard deviations below the
mean for each corpus callosum mask.
Statistical analyses
To assess the reliability of the longitudinal DTI mea-
surements, an intraclass correlation coefficient (ICC)
was calculated for each statistical model by taking the
within-individual variability in the mixed-effects model
and dividing it by the sum of within and between vari-
ability [68]. Because development of the corpus callosum
may not be fully captured by parametric methods, we
took a semi-parametric approach that used penalized
smoothing splines to examine age-related changes in DTI
metrics. These are generalized additive mixed models
[69-72] that also model repeated measurements per sub-
ject, are specially designed for our cohort-sequential sam-
pling plan [73,74], and have been found to have empirical
validity in different applications. These smoothing splines
often bend to data more effectively than polynomials
(while being penalized for each bend to prevent over-
fitting), do not miss important nonlinear growth spurts or
declines, and prevent fitted curve bias at the extremes of
the data range. We used these smooth curves to examine
the effects of age and diagnosis on the tensor coefficients,
after taking into account head motion (TMI), head coil,
and SNR. A centered FSIQ variable was initially included
as a possible covariate, but it was in no case found to
improve the fit significantly and therefore dropped. Fi-
nally, a number of more traditional general linear mixed-
effects models were conducted to confirm the penalized
spline models. Specifically, we divided the sample into
three age groups (less than 10 years of age, 10 to 20 years
of age, and more than 20 years of age) to examine the
main effects of diagnosis and age on DTI metrics as well
as age-by-group interactions within each of these age
brackets.
Results
Longitudinal data reliability and consistency
To examine the reliability of the present DTI data, we
calculated ICCs for each DTI measurement of each sub-
region (see Table 2). The average ICC was 83%, demon-
strating good reliability (although AD of the body of the
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Table 2 Generalized additive mixed-effects models examining group and age-related changes in DTI metrics
Longitudinal DTI changes
Group Age spline Age X group spline
Mean Estimatea P-value EDF F P-value EDF F P-value ICC
Genu FA
ASD and TDC 0.62 −3.12% 0.048 3.45 3.99 0.006 4.67 2.25 0.05 89.7%
ASD 0.61 - - 4.31 2.11 0.075 - - -
TDC 0.63 - - 5.26 5.02 0.0002 - - -
Body FA
ASD and TDC 0.61 −2.40% 0.001 3.99 8.95 **** 6.33 2.41 0.02 88.3%
ASD 0.61 - - 6.59 3.46 0.002 - - -
TDC 0.62 - - 4.25 15.64 **** - - -
Splenium FA
ASD and TDC 0.69 −2.27% 0.04 5.91 9.66 **** 1.00 0.19 0.66 81.1%
ASD 0.69 - - 6.65 6.89 **** - - -
TDC 0.7 - - 3.67 11.54 **** - - -
Genu MD
ASD and TDC 0.76 1.63% 0.46 3.60 8.06 **** 1.00 0.07 0.78 85.9%
ASD 0.76 - - 3.04 5.20 0.002 - - -
TDC 0.75 - - 4.87 7.06 **** - - -
Body MD
ASD and TDC 0.79 1.90% 0.23 3.49 6.39 0.0002 1.30 0.06 0.86 82.4%
ASD 0.79 - - 3.57 6.39 0.0002 - - -
TDC 0.78 - - 3.06 12.13 **** - - -
Splenium MD
ASD and TDC 0.77 1.89% 0.001 1.81 0.53 0.57 4.63 5.62 **** 83.0%
ASD 0.78 - - 4.58 8.25 **** - - -
TDC 0.76 - - 2.96 1.63 0.18 - - -
Genu RD
ASD and TDC 0.37 5.89% 0.23 3.52 3.91 0.006 3.38 1.50 0.21 87.8%
ASD 0.38 - - 3.80 2.75 0.03 - - -
TDC 0.36 - - 4.87 5.89 0.00007 - - -
Body RD
ASD and TDC 0.4 5.33% 0.08 3.89 7.46 0.00001 4.93 1.47 0.20 91.7%
ASD 0.4 - - 5.05 4.11 0.001 - - -
TDC 0.38 - - 4.00 15.00 **** - - -
Splenium RD
ASD and TDC 0.32 7.54% 0.01 4.72 7.92 **** 1.00 0.70 0.40 86.6%
ASD 0.33 - - 5.89 5.55 **** - - -
TDC 0.31 - - 3.34 8.66 **** - - -
Genu AD
ASD and TDC 1.38 −0.28% 0.60 3.99 5.53 0.0002 1.00 0.06 0.81 85.9%
ASD 1.38 - - 3.10 6.10 0.0004 - - -
TDC 1.39 - - 1.87 8.58 0.0005 - - -
Body AD
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corpus callosum had much lower ICC than the rest of
the measurements). Furthermore, to ascertain that our
typically developing data was representative of the popu-
lation at large, we compared this data to previous typic-
ally developing DTI studies with similar age ranges (that
is, [42,43]) and found similar means, ranges, and growth
curves for FA despite differences in data acquisition and
analysis procedures. Therefore, these data demonstrated
good within-individual consistency and consistency with
previous reports.
Longitudinal corpus callosum trajectory models
We tested for case-control differences in the tensor coeffi-
cients (FA, MD, RD, AD) and their longitudinal trajectories.
FA measurements obtained from each of the three subre-
gions of the corpus callosum (that is, the genu, body, and
splenium) can be viewed in Figure 2. A figure of the cor-
tical projections of each subregion of the corpus callosum
can be seen in Additional file 2, which shows that the genu
primarily contains projections to prefrontal cortices, the
body contains projections premotor and supplementary
motor frontal cortices to the primary somatosensory corti-
ces, and the splenium contains projections to the parietal,
occipital, and temporal lobes.
A generalized additive mixed-effects model analysis
suggested decreased mean FA values in individuals with
ASD in each of the corpus callosum subregions (see
Table 2). These significant group differences in mean FA
values were accompanied by a significant term for the
age spline curve. In the genu and body, there were sig-
nificant age-spline-by-group interactions, suggesting that
the developmental trajectories of FA in those regions were
different in the ASD group compared to the typically de-
veloping group. Follow-up linear mixed-effects models in
different age groups (less than 10 years, 10 to 20 years,
and over 20 years) revealed significant age-by-group
Table 2 Generalized additive mixed-effects models examining group and age-related changes in DTI metrics
(Continued)
1.48 −0.005% 0.08 1.00 4.22 0.04 2.19 2.01 0.13 56.6%
1.48 - - 1.93 9.72 0.0001 - - -
1.48 - - 2.66 3.25 0.03 - - -
Splenium AD
1.55 0.35% 0.03 1.67 0.37 0.65 3.55 1.87 0.12 80.0%
1.55 - - 3.47 2.64 0.04 - - -
1.54 - - 3.70 1.64 0.17 - - -
aFor the parametric group differences, the estimate is reported as the percent deviation in the ASD group compared to the TDC group with the corresponding
P-value. For the age spline and the age-by-group splines, the estimated degrees of freedom (EDF), F-value, and P-values are reported. ****P-value <0.00005.
AD, axial diffusivity; ASD, autism spectrum disorder; EDF, estimated degrees of freedom to assess smooth spline complexity; ICC, intra-class correlation coefficient;
FA, fractional anisotropy; MD, mean diffusivity; RD, radial diffusivity; TDC, typically developing controls.
Figure 2 Fractional anisotropy (FA) measures plotted as a function of age and group. ASD, autism spectrum disorder; TDC, typically
developing controls. Time 1 scatter has been adjusted for the head coil changes, and the overlaid growth models for each group represent the
generalized additive mixed model spline curves (with dashed 95% confidence intervals), controlling for head coil changes, total motion index,
signal-to-noise ratio, and random effects.
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interactions for FA in all subregions for individuals
under 10 years of age, but there were no significant in-
teractions for either of the older groups (Table 3).
Plots of MD, RD, and AD measurements obtained from
the corpus callosum subregions are provided in Figure 3.
Table 2 demonstrates significant group differences only in
MD, RD, and AD of the splenium. However, it should be
noted that even though splenium AD had a statistically
significant group difference, it corresponded to a very
small effect size (that is, on a 0.35% increase in AD in
ASD), which means that it might not be a meaningful dif-
ference. The only significant age-by-group interaction was
found in MD of the splenium. As in the FA follow-up
results, linear mixed-effects models suggested that the
majority of interaction effects occurred in the youngest
age group (that is, participants less than 10 years of
age).
Differential analyses
Follow-up analyses examined these same models under
four separate conditions: 1) time 1 only (using 8-channel
head coil), 2) times 2 to 4 (using the 12-channel head
coil), 3) without participants who were on centrally ac-
tive medications, and 4) without participants who were
sedated during scanning. The figures and tables of re-
sults for these differential analyses can be seen in the
supplementary materials (Additional file 1). Without in-
dividuals who were medicated, the pattern of results was
virtually identical. Similarly, when only time 1 was ana-
lyzed, similarly sized main effects and interactions were
present (although some were only marginally significant
due to the loss of three fourths of the data). However,
without the individuals who were sedated during scan-
ning (mostly younger participants) and without the data
from time 1 (when most of the younger children’s data
was collected), significant interaction effects were no
longer present. Therefore, under conditions in which
younger children with ASD were not as represented in
the model, there were no differences in the developmen-
tal trajectories between the ASD group and the typically
developing group. Nevertheless, because many of the
younger children’s scans are confounded with sedation
effects, the present study cannot definitively disentangle
atypical early development of the corpus callosum from
sedation effects in these models.
Discussion
The present study used a cohort sequential design and
generalized additive spline models to examine age-
related trajectories of white matter microstructure of the
corpus callosum in ASD compared to typical develop-
ment. We aimed to longitudinally investigate develop-
ment of corpus callosum microstructure in ASD from
3 years of age through the final stages of corpus
callosum development in young adulthood. Even after
controlling for known confounds in the imaging litera-
ture such as head motion and SNR, the longitudinal results
yielded significant group differences in the microstructure of
corpus callosum across the entire period. FA appeared to be
atypically increased during early childhood. Its developmen-
tal trajectory during the first 10 years of life was in the
opposite direction of typical development; FA decreased
during childhood in the ASD group but increased as ex-
pected in TDC children. The ASD and TDC FA curves
crossed during childhood, leading to a sustained decrease
in FA in the ASD group relative to TDC during adoles-
cence and young adulthood. Developmental abnormalities
were found in all three subdivisions of the corpus callo-
sum examined, predominantly affecting FA in the genu
and body and MD in the splenium. These overall observa-
tions are bolstered by relative individual consistency of the
longitudinal DTI measurements across the study and the
consistency of these results with other investigations.
Developmental differences in microstructure of corpus
callosum
The present study demonstrated significant group differ-
ences in the developmental trajectory of the microstructure
of the genu and body (FA). This atypical developmental
trajectory in ASD was characterized by atypically high FA
values in early childhood that decreased with age, crossed
the TDC curve, and plateaued below the FA values of the
typically developing group. Follow-up analyses conducted
within particular age brackets reiterated that the develop-
mental slope of FA was atypical only in the youngest ASD
cohort (less than 10 years of age). This result is consistent
with the only previous longitudinal investigation of corpus
callosum microstructure in ASD [44], which examined
microstructure in infants (6 to 24 months of age) and
found atypical developmental trajectories of FA in the cor-
pus callosum of the group that went on to develop ASD.
Our sample did not overlap in age with the Wolff et al.
study [44], but our results converge to suggest higher cor-
pus callosum FA in early childhood in ASD that may de-
crease with age. Cross-sectional studies have also found
increased FA in young children with autism [32,35,75,76].
Our result of crossing of the ASD and TDC corpus callo-
sum FA growth curves at about 7 years of age is consistent
with age-related findings in a cross-sectional study that
suggested crossing between 7 and 8 years of age [76]. Inter-
secting of the corpus callosum FA growth curve during late
childhood is consistent with cross-sectional studies at this
age that have found no group differences [77,78].
We also found atypical longitudinal development of cor-
pus callosum microstructure during adolescence and young
adulthood. FA of the genu and body was persistently
decreased; rate of change was similar to the TDC group.
Cross-sectional studies of ASD have consistently found
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Table 3 Results of standard linear mixed-effects models for different age groups within the sample
Intercept Group P-value Age P-value Age X Group P-value
Genu FA
<10 years old 0.73 −0.22a <0.001 0.010 0.03 −0.0189 0.002
10 to 20 years old 0.63 −0.02 0.04 0.001 0.48 0.0002 0.89
>20 years old 0.65 −0.04 0.004 −0.003 0.004 0.0019 0.09
Body FA
<10 years old 0.69 −0.15 0.003 0.009 0.02 −0.0129 0.008
10 to 20 years old 0.64 −0.02 0.01 0.005 <0.001 −0.0019 0.12
>20 years old 0.65 −0.03 0.03 −0.002 0.03 0.0009 0.45
Splenium FA
<10 years old 0.77 −0.15 0.006 0.008 0.06 −0.0110 0.03
10 to 20 years old 0.71 −0.01 0.11 0.002 0.01 0.0001 0.94
>20 years old 0.72 −0.02 0.01 −0.001 0.23 0.0010 0.26
Genu MD
<10 years old 0.66 0.15 0.008 −0.011 0.02 0.0130 0.02
10 to 20 years old 0.75 0.01 0.22 −0.001 0.19 −0.0002 0.85
>20 years old 0.72 0.02 0.07 0.002 0.008 −0.0008 0.41
Body MD
<10 years old 0.76 0.08 0.12 −0.006 0.14 0.0050 0.30
10 to 20 years old 0.78 0.01 0.24 −0.003 0.007 −0.0004 0.75
>20 years old 0.76 0.02 0.12 0.001 0.19 −0.0004 0.74
Splenium MD
<10 years old 0.75 0.07 0.30 −0.003 0.57 0.0028 0.63
10 to 20 years old 0.77 0.01 0.40 −0.001 0.28 0.0004 0.73
>20 years old 0.74 0.02 0.048 0.002 0.01 −0.0011 0.28
Genu RD
<10 years old 0.23 0.28 0.001 −0.014 0.04 0.0236 0.005
10 to 20 years old 0.37 0.02 0.10 −0.001 0.34 −0.0005 0.74
>20 years old 0.32 0.04 0.009 0.004 0.004 −0.0020 0.15
Body RD
<10 years old 0.34 0.14 0.006 −0.010 0.02 0.0115 0.02
10 to 20 years old 0.38 0.02 0.03 −0.005 <0.001 0.0009 0.48
>20 years old 0.35 0.03 0.03 0.003 0.02 −0.0009 0.48
Splenium RD
<10 years old 0.26 0.17 0.01 −0.006 0.22 0.0113 0.08
10 to 20 years old 0.30 0.01 0.10 −0.002 0.049 −0.0001 0.92
>20 years old 0.28 0.03 0.007 0.002 0.04 −0.0013 0.26
Genu AD
<10 years old 1.35 −0.03 0.68 −0.008 0.12 −0.0019 0.75
10 to 20 years old 1.40 −0.01 0.20 −0.001 0.41 −0.0012 0.54
>20 years old 1.36 −0.01 0.66 0.000 0.76 0.0005 0.70
Body AD
<10 years old 1.47 0.03 0.73 −0.004 0.54 −0.0012 0.87
10 to 20 years old 1.51 −0.03 0.02 0.003 0.15 −0.0054 0.02
>20 years old 1.49 −0.02 0.30 −0.002 0.15 0.0014 0.41
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decreased FA in adolescents and adults with ASD
[27-31,79-85]. The longitudinal trajectories depicted in our
models of corpus callosum FA demonstrate that the in-
consistencies that have been noted in the corpus callosum
DTI in ASD literature are likely due to the different age
ranges of the different studies. The present group differences
are also consistent with functional connectivity findings of
decreased interhemispheric connectivity in ASD [2,17-19]. It
is possible that the present findings of decreased struc-
tural connectivity of the corpus callosum in ASD may
correspond to these functional differences, although a
direct comparison will be needed to confirm this rela-
tion. Recent evidence suggests that the relationship
between structural connectivity indexed by DTI and
Figure 3 Mean diffusivity (MD), radial diffusivity (RD), and axial diffusivity (AD) measures plotted as function of age and group. ASD,
autism spectrum disorder; TDC, typically developing controls. Time 1 scatter has been adjusted for the head coil changes, and the overlaid
growth models for each group represent the generalized additive mixed model spline curves (with dashed 95% confidence intervals), controlling
for head coil changes, total motion index, signal-to-noise ratio, and random effects.
Table 3 Results of standard linear mixed-effects models for different age groups within the sample (Continued)
Splenium AD
<10 years old 1.61 −0.07 0.30 0.007 0.18 −0.0091 0.17
10 to 20 years old 1.56 −0.01 0.33 0.001 0.51 −0.0003 0.86
>20 years old 1.53 0.01 0.56 0.001 0.71 −0.0003 0.87
Age groups were defined as less than 10 years old, 10 to 20 years old, and greater than 20 years old. The analyses in those under 10 years of age included 34
individuals with ASD (48 scans) and 12 individuals with typical development (17 scans). The analyses in those between 10 and 20 years of age included 61
individuals with ASD (127 scans) and 34 individuals with typical development (67 scans). The analyses in those over 20 years of age included 46 individuals with
ASD (112 scans) and 29 individuals with typical development (63 scans). The mixed effects models examined diagnostic group main effects (ASD versus typical
development), age main effects, and age-by-group interactions for FA, MD, RD, and AD of the genu, body, and splenium of the corpus callosum. The mixed effect
model was denoted as DTI metric ~ 1 + group + age (years) + group × Age + (1 | participant), while controlling for head motion, SNR, and head coil. All intercepts
were statistically significant. aWhile this group effect is negative, caution should be employed when interpreting the direction of main effects in the presence of
significant interactions. Graphically, the data demonstrate that most of the children under the age of 10 in the ASD group have higher levels of FA than in the
typically developing group.
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resting state functional connectivity across the lifespan
is complex [86].
In addition to differences in FA, the only corpus callo-
sum region that the ASD group exhibited significantly
increased MD, RD, and AD was in the splenium, al-
though the effect size of the splenium AD was much
smaller than the other effects. Further, there was a sig-
nificant group difference in the developmental trajectory
of splenium MD, but this should be interpreted with
caution because our follow-up analyses did not converge
to show that this was a significant effect in any of our
age brackets. Although DTI measures do not specify the
type of white matter microstructural changes that may
be present (for example, myelination, axonal size and
packing, or glial cellularity), the present results (decreased
FA the splenium in conjunction with increased MD and
RD [but smaller effect sized for group differences in AD])
are consistent with abnormal myelination in ASD [24].
Speculatively, factors such as atypical early development
or maintenance of myelin (occurring before birth or in the
first few years of life) could be underlying these brain dif-
ferences in ASD. These mechanisms may be better eluci-
dated in future research through animal and human
postmortem myelination studies or by combining in vivo
DTI with more specific imaging measures of myelination,
including multicomponent relaxometry and magnetization
transfer [24]. Although MD and RD of the genu did not
exhibit significant group differences, it should be noted
that these non-significant effects were in the same direc-
tion as the splenium effects. Therefore, it may be reason-
able to assume that the underlying mechanisms may be
similar across the corpus callosum.
It is further important to note that we observed great
variability in the corpus callosum DTI values of the ASD
group. As can be seen in the individual data points pre-
sented in Figure 2, there were a number of individuals
with ASD who had typical corpus callosum values and
a subset of individuals with ASD who demonstrated
atypically low FA, high MD, and high RD. In the time
1 analyses of this data, Alexander et al. noted that
group differences in the corpus callosum DTI metrics
appeared to be driven by a minority of ASD partici-
pants [27]. The present longitudinal results extend
upon those findings to show that the heterogeneity in
the ASD group remained and that this subset of partic-
ipants continued to show atypical DTI values across
the 9-year period of this study. Future studies will in-
vestigate behavioral and genetic contributions to the
variation in FA/MD in the participants with extreme
corpus callosum values.
The role of the corpus callosum in autism
Corpus callosum group differences have been the most
consistently reported finding in the DTI in ASD literature
[25]. Additionally, the corpus callosum repeatedly has
been shown to be smaller in ASD [15,16], and functional
imaging studies have demonstrated correlations between
functional connectivity measures and the size of relevant
regions of the corpus callosum [2,87-89]. The present lon-
gitudinal results reiterate corpus callosum pathology in
ASD, and while white matter outside of the corpus callo-
sum has been found to be affected in ASD, the corpus cal-
losum should be given special consideration because of its
size and of its participation in more global brain develop-
ment. Specifically, the corpus callosum is the largest white
matter tract in the brain, and it is known to reciprocally
affect cortical development (see [46] for a review), which
means that the corpus callosum could be intimately in-
volved in the development of other structural brain
differences that are observed in ASD. Indeed, atypical
development of cortical thickness has been longitudin-
ally observed in this sample [90], and future studies
are critically needed to examine if corpus callosum
atypicalities precede or co-occur with cortical thick-
ness atypicalities in ASD.
Although there is converging evidence across multiple
lines of research that suggest that the corpus callosum is
commonly affected in ASD, the critical question of how
corpus callosum atypicalities relate to the core behav-
ioral symptoms of ASD remains. The similarity in some
of the cognitive and symptom profiles between individ-
uals with callosal agenesis and individuals with ASD is
intriguing [91-93]. However, neither the literature nor
the present study has established a one-to-one link be-
tween core ASD symptomatology and the corpus callo-
sum. Perhaps, this is driven by the diversity of cognitive
functions related to the corpus callosum [6], the devel-
opment of compensatory mechanisms to accommodate
corpus callosum atypicalities [94], the heterogeneity of
symptom profiles within the ASD diagnosis, or the way
in which corpus callosum development may be affecting
or affected by cortical development [46]. Future research
is needed to investigate how variation in specific neuro-
cognitive functions may relate to variation in corpus cal-
losum microstructure. Longitudinal studies provide the
opportunity to discern causal pathways between alter-
ations of brain structure, microstructure, and function
and cognitive and behavioral impairments. Elucidation
of causal pathways and mediating mechanisms, and de-
velopment of predictive models, will pave the way for
the formation of new biologically informed interventions
and their targeted use in specific ASD subgroups.
Limitations
There are several potential limitations associated with this
present study. First, a limitation of the cohort sequential
design is the use of a multiple cohorts across ages, which
may make this design less sensitive to age-specific changes
Travers et al. Molecular Autism  (2015) 6:15 Page 11 of 14
during narrow windows of development. However, the
cohort sequential design allowed us to more rapidly
answer this key longitudinal question in autism than
would have been possible with a longitudinal panel design,
and the accelerated design also minimized potential cohort-
related confounds [95]. A second possible limitation is that
the DTI protocol was held as consistent as possible across
all data collection in this longitudinal study, despite the
fact that more optimal protocols (for example, more
than 12 directions, isotropic spatial resolution) have
been developed over the years. In addition, there were
unforeseeable changes in the hardware (head coil) and
subsequent product DTI pulse sequence (TE) between
time 1 and time 2 that resulted in a systematic bias in
DTI measures between these two time points. As a result,
a covariate for scanner was included in the age-trajectory
models, which appears to have removed the bias associ-
ated with the imaging time point. The corrected measures
were highly consistent across all time points, and the
models were very similar without individuals with medica-
tion and when only time 1 data were included. However,
the interaction effects were not sustained when eliminat-
ing participants under sedation and only times 2 through
4 data (both strategies that eliminated our youngest par-
ticipants), which means that we cannot definitively disam-
biguate between the effects of age or sedation on our
group differences in developmental trajectories. Sedation
during pediatric neuroimaging has been shown to be safe
and effective [96], and while there is evidence that there
could be minimal effects of sedation on DTI metrics in
temporal white matter [97], it is unclear whether this is
due to the actual sedation or to the fact that the most se-
verely impacted individuals with ASD were most likely to
be sedated. Therefore, the effects of sedation on DTI are
still unclear and will need to be elucidated in future re-
search. Our study focused on verbal males to decrease
heterogeneity in the ASD sample and increase statistical
power. Additional studies of females and intellectually
low-functioning individuals are needed to determine if the
findings of the present study generalize to these groups.
Finally, given the heterogeneity present even in verbal
males with autism, replication of our findings in an inde-
pendent sample is needed.
Conclusions
The present study used DTI methods to longitudinally
examine the white matter microstructure of the corpus
callosum in individuals with ASD compared to typically
developing controls (ages 3 to 41 years). The results sug-
gest that corpus callosum microstructure (especially in
the anterior corpus callosum) develops atypically in aut-
ism before the age of 10 years and that this early atypical
development becomes a persistent group difference in
later childhood, adolescence, and adulthood. Because the
corpus callosum is the largest white matter tract in the
brain, corpus callosum atypicalities likely have lasting effects
on many aspects of cognition and brain synchronization
in ASD.
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Additional file 1: Supplementary materials for differential analyses.
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cortical projections of the genu (red), body (green), and splenium (blue)
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